Northland Capital Markets initiated coverage on Trident Acquisitions with a new price target
$TDAC
Northland Capital Markets initiated coverage of Trident Acquisitions with a rating of Outperform and set a new price target of $16.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/21/2021 | $16.00 | Outperform | Northland Capital Markets |
NEW YORK, July 6, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE:TDAC) ( "TDAC") announced that ProLogium has filed their initial F-4 with the SEC driving the companies forward towards a successful execution of the de-SPAC transaction. This filing gives the SEC and investors at large a fuller view into the history of ProLogium and further supporting information into the merger transaction that was announced on May 27, 2026. Michael Hoffman, Chairman and CEO of TDAC, commented, "We continue to be tremendously excited to work with the ProLogium team on this transaction. We believe that this F-4 filing with the SEC will provide investors significant color into the comp
85% of Shares are not Redeemed, resulting in TDAC maintaining $156.8mm in trust95% of the Shares Voted Were In Favor of the ExtensionThese Great Results Follow the Momentum of the May 27, 2026 announcement of TDAC's Entry into a Merger Agreement with PrologiumPrologium is a global leader in next generation lithium ceramic battery technology, moving into growth markets, including AI Data Centers, aerospace, robotics, defense and electric vehiclesNEW YORK, June 22, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE:TDAC) (the "Company" or "TDAC") announced the very successful results of the shareholder vote held on 6/17/26 regarding the proposed extension of the SPAC life
ProLogium reached commercial-scale manufacturing for solid-state batteries in 2013, later delivered the world's first solid-state battery demo car with ENOVATE Motor in 2019. ProLogium has shipped a total of over 2.4 million battery cells to customers since 2013, of which more than 800,000 are its 3rd-generation batteries from the Gigafactory in Taiwan. With a portfolio of 1,100+ patents, ProLogium has introduced its 4th-generation superfluidized inorganic solid-state battery solution with zero thermal runaway, high energy density, low temperature performance, fast charging, competitive cost, and commercial readiness. Pre-money valuation of ProLogium is expected to be approximately $3.8 bill
4 - Translational Development Acquisition Corp. (0001926599) (Issuer)
3 - Translational Development Acquisition Corp. (0001926599) (Issuer)
3 - Translational Development Acquisition Corp. (0001926599) (Issuer)
SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
DEFA14A - Translational Development Acquisition Corp. (0001926599) (Filer)
Northland Capital Markets initiated coverage of Trident Acquisitions with a rating of Outperform and set a new price target of $16.00
SC 13G - Trident Acquisitions Corp. (0001673481) (Subject)